Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The editorial highlights the steady growth in submissions, publications, and the increasing impact factor of the ESC Heart Failure journal.
ESC Heart Failure (ESC-HF) is an open access journal focused on advancing the understanding of heart failure since 2014. It is one of two journals of the Heart Failure Association of the European Society of Cardiology (European Journal of Heart Failure & ESC Heart Failure). ESC-HF is published by Wiley as its publishing house. The journal's main topics include basic and translational research questions regarding the pathophysiology, electrophysiology, and biology of heart failure; clinical questions regarding the prevention, diagnosis, understanding, and therapy of heart failure; and epidemiological questions regarding the incidence, prevalence, prevention, distribution, and risk factors for heart failure in different populations. The workload regarding submitted journals is distributed between Prof. Stefan D. Anker (Berlin, Germany), the editor-in-chief, and the three deputy editors Prof. Stephan von Haehling (Göttingen, Germany) for the clinical section, Prof. Zoltán Papp (Budapest, Hungary) for the basic science section, and Dr Gábor Földes (London, UK, and Budapest, Hungary) for translational research. However, the journal would not be feasible without the help of the many authors and reviewers, editorial board members, associate editors, and especially the editorial office with Monika Diek, Anja Janssen, and Corinna Denecke. This journal relies on all these people to work together, towards the same goal of better understanding heart failure and its treatment. While in 2014, new journal issues were published every 6 months, today every 2 months a new issue is published. Thereby, the number of articles steadily increased over the years—2014, 16; 2015 and 2016, both 41; 2017, 95; 2018, 131; and 2019, 149. This is a ninefold increase of published articles from 2014 until 2019. At the time of this writing in September 2020, the number of submissions in 2020 has reached 926. The journal attracts publications from many different nations. The list of countries where most of the articles originate includes Germany, the United States, Japan, England, Italy, Netherland, Spain, Sweden, France, and Australia. In Web of Science,66ESC-HF is currently ranked number 44 of 138 journals in the ‘cardiac & cardiovascular systems’ section. The top 10 best cited papers ever published in ESC-HF (Table 1) so far on average have already been cited 39 times. These top 10 papers included five original articles, two reviews, and even three editorials, showing that ESC-HF does not only publish original articles but also state-of-the-art reviews and editorials. This is confirmed when looking at the top 20 papers published in 2017–2019 (Tables 2-4). In 2017, this included 15 original articles, three reviews, and two editorials; in 2018, 14 original articles and six reviews; and in 2019, 15 original articles, four reviews, and one editorial. Sixteen papers from 2017 and 2018 have been already cited ≥20 times, and even of the 2019 papers, three papers have already been cited ≥10 times. In 2019, ESC-HF articles were altogether cited 1276 times.66 Of these citations, 835 (65%) were to papers published in 2017/2018. ESC-HF published 214 citable articles in 2017 and 2018. This is important to know, because the 2019 Thomson Scientific journal impact factor of each journal (which is believed the most important rating tool for journals in Europe and the USA) was calculated by dividing the 2019 citations to articles published in 2017 and 2018 by the number of citable articles in 2017 and 2018. Hence, the 2019 journal impact factor of ESC-HF is 3.902 (835/214).66 Considering that the 2018 impact factor of ESC-HF was 3.407, this is an increase by 15% in just 1 year, which we think is great success. This shows that the hard work of all researchers, editors, associates, and reviewers that has been put into the articles published in the last years in ESC-HF is being recognized by the scientific community. We want to continue this path in the future and thank all people that are involved in ESC-HF, helping to publish scientific papers, with the goal to improve the understanding, prevention, and treatment of heart failure. None declared.
No takes yet. Share an insight, caveat, or question.
Anker et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: